The effect of dapagliflozin treatment on epicardial adipose tissue volume

The effect of dapagliflozin treatment on epicardial adipose tissue volume

Abstract Background Glycosuria produced by sodium–glucose co-transporter-2 (SGLT-2) inhibitors is associated with weight loss. SGLT-2 inhibitors reportedly might reduce the occurrence of cardiovascular events. Epicardial adipose tissue (EAT) is a pathogenic fat depot that may be associated with coro...

Full description

Bibliographic Details
Main Authors: Takao Sato, Yoshifusa Aizawa, Sho Yuasa, Shohei Kishi, Koichi Fuse, Satoshi Fujita, Yoshio Ikeda, Hitoshi Kitazawa, Minoru Takahashi, Masahito Sato, Masaaki Okabe
Format: Article
Language:English
Published: BMC 2018-01-01
Series:Cardiovascular Diabetology
Subjects:
SGLT-2 inhibitor
Epicardial adipose tissue
Diabetes mellitus
Online Access:http://link.springer.com/article/10.1186/s12933-017-0658-8

Internet

http://link.springer.com/article/10.1186/s12933-017-0658-8

Similar Items